✦ LIBER ✦

Effect of odanacatib on bone structure in postmenopausal women with low BMD

✍ Scribed by A. Man-Wei Cheung⁎; K. Brixen; R. Chapurlat; S. Majumdar; A. Cabal; N. Verbruggen; S. Ather; E. Rosenberg; A. de Papp

Book ID: 116325262
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 114 KB
Volume: 50
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2012.02.155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Odanacatib treatment in postmenopausal w

Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results

✍ M. McClung; J.A. Eisman; H.G. Bone; C. Roux; R.R. Recker; N. Verbruggen; C.M. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Treatment with the cathepsin K inhibitor

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial

✍ B. Langdahl⁎; N. Binkley; H. Bone; N. Gilchrist; H. Resch; J. Rodriguez Portales 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Treatment with the cathepsin K inhibitor

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial

✍ H. Resch; N. Binkley; H. Bone; J.A. Eisman; N. Gilchrist; B. Langdahl; J. Rodrig 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: 3-year continued therapy and resolution of effect

✍ D. Hosking⁎; J.A. Eisman; H. Bone; M. McClung; I. Reid; R. Rizzoli; H. Resch; N. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Odanacatib in the Treatment of Postmenop

Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect

✍ Ian Reid; John Eisman; Henry Bone; David Hosking; Michael McClung; Rene Rizzoli; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB